A Perioperative Hydrogel Platform for Integrated Endoscopic Submucosal Dissection Management
ACS Applied Materials & Interfaces · 2026
DOI: 10.1021/acsami.6c01648 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Zizhao Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Materials and Chemistry, University of Shanghai for Science and Technology, No. 516 Jungong Road, Shanghai 200093, P. R. China. Hauptthemen laut MEDLINE: Hydrogels, Endoscopic Mucosal Resection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Shanghai Municipal Health Commission, Shanghai Fourth People's Hospital, Tongji University.
Abstract (Originalsprache)
Endoscopic submucosal dissection (ESD), a minimally invasive procedure, is constrained by the rapid dissipation of conventional submucosal cushions and the absence of sustained postoperative therapeutic support. Herein, we develop a multifunctional hydrogel integrating mucosal elevating, sustained local analgesia, wound protection, antibacterial and antioxidant capabilities for perioperative management of ESD. The hydrogel is formed via Schiff base reactions between carboxymethyl chitosan and oxidized dextran, incorporates methylene blue for intraoperative visualization, and integrates mesoporous silica nanoparticles loaded with Bupivacaine (BUP@MSNs) to enable local sustained-release analgesia. Targeting critical limitations of conventional mucosal elevating agents, the hydrogel rapidly forms a stable submucosal cushion through in situ gelation, enhancing ESD procedural efficiency and safety while enabling immediate wound sealing and protection. Under physiological conditions, the hydrogel exhibits excellent injectability, self-healing capacity, and tissue adhesion at the lesion site. It also exerts potent antioxidant and antibacterial activities, fulfilling requirements for perioperative microenvironment modulation. Furthermore, the hydrogel delivers early postoperative analgesia that persists for over 48 h, effectively covering the peak pain phase post-ESD. Comprehensive in vitro and in vivo safety evaluations confirm its favorable biocompatibility and tolerability. Collectively, the hydrogel represents an integrated, clinically operable, and cost-effective candidate for gastrointestinal endoscopic minimally invasive therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Materials and Chemistry, University of Shanghai for Science and Technology, No. 516 Jungong Road, Shanghai 200093, P. R. China.
- Department of Anesthesiology and Perioperative Medicine, Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational R…
- Department of Gastroenterology, Changhai Hospital, Naval Medical University, No. 168 Changhai Road, Shanghai 200433, P. R. China.
ORCID-Profile: Shige Wang
Förderung
- Shanghai Municipal Health Commission
- Shanghai Fourth People's Hospital, Tongji University
Zitieren
APA
Wang, Z., Yang, Y., Sun, H., Fan, P., Jia, X., Zhang, L., Wang, T., Zhao, J., Chen, Q., & Wang, S. (2026). A Perioperative Hydrogel Platform for Integrated Endoscopic Submucosal Dissection Management. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c01648
Vancouver
Wang Z, Yang Y, Sun H, Fan P, Jia X, Zhang L, et al. A Perioperative Hydrogel Platform for Integrated Endoscopic Submucosal Dissection Management. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c01648
BibTeX
@article{Wang2026,
author = {Wang, Zizhao and Yang, Yang and Sun, Hongxin and Fan, Peng and Jia, Xiaoqing and Zhang, Liang and Wang, Ting and Zhao, Jiulong and Chen, Qian and Wang, Shige},
title = {A Perioperative Hydrogel Platform for Integrated Endoscopic Submucosal Dissection Management},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c01648}
}
EUVIMED